We are live on
!
Find out more
AWMM
Aegis Wealth Management (Maryland) Portfolio holdings
AUM
$213M
1-Year Est. Return
23.41%
This Fund
S&P 500
This Quarter
Est. Return
+0.84%
1 Year Est. Return
+23.41%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$175M
AUM Growth
-$2.05M
(-1.2%)
Cap. Flow
-$3.13M
Cap. Flow
% of AUM
-1.79%
Top 10 Holdings %
Top 10 Hldgs %
41.08%
Holding
124
New
3
Increased
38
Reduced
50
Closed
6
Avg Time Held
4.3
quarters
Top 10 Avg Time Held
3.5
quarters
Top 20 Avg Time Held
4
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dyne Therapeutics
DYN
|
+$1.02M |
| 2 |
VBIL
Vanguard 0-3 Month Treasury Bill ETF
VBIL
|
+$859K |
| 3 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$274K |
| 4 |
Elevance Health
ELV
|
+$264K |
| 5 |
PepsiCo
PEP
|
+$248K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.35M |
| 2 |
Apple
AAPL
|
+$740K |
| 3 |
Dimensional US Marketwide Value ETF
DFUV
|
+$550K |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$460K |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$455K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 84.32% |
| 2 | Materials | 2.7% |
| 3 | Healthcare | 2.58% |
| 4 | Technology | 2.2% |
| 5 | Financials | 1.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Albemarle
ALB
$12.3B
| $719K | 0.41% |
4,003
+1
| +0% | +$171 |
2025 Q3
2 quarters
|
|
52
Schwab Short-Term US Treasury ETF
SCHO
$15.2B
| $717K | 0.41% |
29,546
-92
| -0.3% | -$2.24K |
2024 Q4
5 quarters
|
|
53
Avantis US Small Cap Value ETF
AVUV
$30.9B
| $704K | 0.4% |
6,376
+400
| +7% | +$44K |
2024 Q4
5 quarters
|
|
54
Philip Morris
PM
$292B
| $697K | 0.4% |
4,214
-108
| -2% | -$18.8K |
2024 Q4
5 quarters
|
|
55
Schwab Emerging Markets Equity ETF
SCHE
$12.8B
| $674K | 0.39% |
20,463
-206
| -1% | -$7.03K |
2024 Q4
5 quarters
|
|
56
Alcoa
AA
$11.1B
| $664K | 0.38% |
10,008
| – | – |
2025 Q3
2 quarters
|
|
57
Duke Energy
DUK
$89B
| $655K | 0.37% |
4,999
-1,044
| -17% | -$131K |
2024 Q4
5 quarters
|
|
58
Johnson & Johnson
JNJ
$617B
| $605K | 0.35% |
2,477
-224
| -8% | -$52.2K |
2024 Q4
5 quarters
|
|
59
iShares 0-3 Month Treasury Bond ETF
SGOV
$111B
| $604K | 0.35% |
6,000
+2,400
| +67% | +$241K |
2025 Q3
2 quarters
|
|
60
BP
BP
$115B
| $603K | 0.35% |
12,840
+1,258
| +11% | +$49.3K |
2024 Q4
5 quarters
|
|
61
iShares Global REIT ETF
REET
$4.62B
| $592K | 0.34% |
23,555
+1,542
| +7% | +$40K |
2024 Q4
5 quarters
|
|
62
Medtronic
MDT
$110B
| $520K | 0.3% |
6,006
-422
| -7% | -$40.4K |
2024 Q4
5 quarters
|
|
63
iShares Core MSCI Total International Stock ETF
IXUS
$59.1B
| $520K | 0.3% |
6,000
| – | – |
2024 Q4
5 quarters
|
|
64
Entergy
ETR
$48.2B
| $501K | 0.29% |
4,457
-323
| -7% | -$32.5K |
2024 Q4
5 quarters
|
|
|
B
65
Barrick Mining
B
$66.2B
| $489K | 0.28% |
12,000
| – | – |
2024 Q4
5 quarters
|
|
66
MP Materials
MP
$8.37B
| $483K | 0.28% |
10,005
| – | – |
2024 Q4
5 quarters
|
|
67
Dimensional International Small Cap ETF
DFIS
$5.78B
| $478K | 0.27% |
14,201
| – | – |
2024 Q4
5 quarters
|
|
68
Dimensional International Small Cap Value ETF
DISV
$5.11B
| $464K | 0.27% |
11,772
| – | – |
2024 Q4
5 quarters
|
|
69
Schwab US Dividend Equity ETF
SCHD
$108B
| $463K | 0.27% |
15,100
| – | – |
2024 Q4
5 quarters
|
|
70
Vanguard Financials ETF
VFH
$12.5B
| $459K | 0.26% |
3,800
| – | – |
2024 Q4
5 quarters
|
|
71
Schwab US REIT ETF
SCHH
$10.5B
| $452K | 0.26% |
21,038
+137
| +0.7% | +$3K |
2024 Q4
5 quarters
|
|
72
GSK
GSK
$94.2B
| $426K | 0.24% |
7,716
-139
| -2% | -$7.53K |
2024 Q4
5 quarters
|
|
73
Dimensional Global Core Plus Fixed Income ETF
DFGP
$3.53B
| $397K | 0.23% |
7,362
+317
| +4% | +$17.3K |
2024 Q4
5 quarters
|
|
74
Vert Global Sustainable Real Estate ETF
VGSR
$474M
| $390K | 0.22% |
37,766
+655
| +2% | +$7.05K |
2024 Q4
5 quarters
|
|
75
Rayonier
RYN
$5.37B
| $389K | 0.22% |
18,878
| – | – |
2025 Q3
2 quarters
|
|
Similar funds
GL
LFIA
FCB
KCM
IAIM
4FG
CCWP
EPIM
Aegis Wealth Management (Maryland)'s Q1 2026 Portfolio in Review
As of Q1 2026, Aegis Wealth Management (Maryland) held 124 positions worth $175M, down 1.2% from $177M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Aegis Wealth Management (Maryland)'s Q1 2026 filing shows 3 new, 38 increased, 50 reduced and 6 closed positions. Its largest new stake was Elevance Health: 802 shares worth $235K. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.35M.
By sector, the portfolio is most concentrated in Miscellaneous at 84% of assets, up from 84% a quarter earlier, followed by Materials and Healthcare.
- Aegis Wealth Management (Maryland)'s largest Q1 2026 buy was Elevance Health: 802 shares worth $235K.
- Aegis Wealth Management (Maryland) added most to Dyne Therapeutics in Q1 2026, an estimated $1.02M increase.
- Aegis Wealth Management (Maryland)'s biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.35M.
- Aegis Wealth Management (Maryland) fully exited Bristol-Myers Squibb in Q1 2026, selling an estimated $326K.
- Aegis Wealth Management (Maryland)'s ten largest holdings make up 41% of its $175M portfolio in Q1 2026.
- Aegis Wealth Management (Maryland) opened 3 new positions and closed 6 in Q1 2026.
- Aegis Wealth Management (Maryland)'s portfolio value fell 1.2% quarter-over-quarter to $175M.
Based on Aegis Wealth Management (Maryland)'s 13F filing for Q1 2026, filed 23 Apr 2026.